Longevity Health Holdings Secures Up to $625K Financing from Puritan Partners
Longevity Health Holdings announces a Securities Purchase Agreement with Puritan Partners for up to $625,000 in gross proceeds via convertible notes, drawing an initial $375,000 tranche.
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
PITTSBURGH, Sept. 08, 2026 (GLOBE NEWSWIRE) — Longevity Health Holdings, Inc. (OTCQB: XAGE) (“Longevity” or the “Company”) today announced that it has entered into a Securities Purchase Agreement with Puritan Partners LLC (“Puritan”) providing for up to $625,000 in aggregate gross proceeds to the Company through a series of 10% senior secured convertible notes, each issued with a 10% original issue discount (the “Purchase Agreement”).
“We’re pleased to deepen our relationship with Puritan Partners through this new facility, which gives Longevity additional financial flexibility as we continue to build out our regenerative bio-aesthetics platform and pursue other strategic opportunities,” said Janakiram Ajjarapu, Chairman and Chief Executive Officer of the Company. “The agreement with Puritan gives us room to draw additional capital as we achieve key milestones.”
At the initial closing on August 31, 2026, the Company received initial gross proceeds of $375,000, before fees and expenses, through the issuance of a note due February 29, 2028, with a 10% original issue discount, in the original principal amount of $416,666.67 (the “Note”). The Note bears interest at 10% per annum and is convertible into shares of the Company’s common stock at a conversion price of $0.50 per share, subject to adjustment. The Note is secured by substantially all of the assets of the Company and its subsidiaries.
The Purchase Agreement provides for the potential issuance to Puritan of two additional notes, each for $125,000 in gross proceeds to the Company, on substantially the same terms as the Note, in an aggregate principal amount of up to $277,778. The second tranche of the notes is subject to the effectiveness of a resale registration statement covering the underlying shares, and the third tranche is at Puritan’s sole discretion.
Additional information regarding the terms of the Note and related transaction documents is included in the Company’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on September 4, 2026.
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc. is focused on longevity and healthy aging, encompassing the latest scientific advances in regenerative bio-aesthetics. The Company develops, manufactures, and markets cosmetic skincare and haircare products designed to help people look and feel their best at any age. The Company is headquartered in Pittsburgh, Pennsylvania. For more information, visit www.healthxage.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the anticipated benefits of the Purchase Agreement, the Company’s plans to pursue additional financing, and the Company’s future business and financial condition. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including the risk that anticipated additional financing is not completed on the terms described or at all, risks relating to the Company’s obligations under the Purchase Agreement and the related financing instruments, including potential dilution, security interests in substantially all Company assets and specified subsidiary assets, repayment and prepayment obligations, and default-related remedies, and other risks described in the Company’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update any forward-looking statements, except as required by law.
Contact
Bryan J. Cassaday
bcassaday@healthxage.com
Media gallery
